论文部分内容阅读
目的评价子宫输卵管造影同时在透视下通液联合瘀通一号口服治疗输卵管阻塞的临床应用价值。方法随访及分析河北大学附属医院近1年确诊为输卵管阻塞性不孕的病例。根据患者的治疗情况,分为治疗组及对照组。治疗组均行子宫输卵管造影并随即在透视下通液后内服中药,组方以活血化瘀、调经补肾为法,根据辨证加减或辅以周期疗法;对照组仅采取常规通液治疗。统计并对比分析两组输卵管再通率及妊娠率。结果研究表明治疗组输卵管再通率达98%,宫内妊娠率高达75.6%,而仅采取常规通液治疗的对照组输卵管再通率仅78.4%,妊娠率也仅有52.9%,两组的输卵管再通率及宫内妊娠率比较差异有统计学意义;且半年至1年内宫内妊娠率比较差异有统计学意义。治疗组明显优于对照组。结论输卵管阻塞性不孕症患者经子宫输卵管造影及透视下通液、配合以中药内服的中西医结合治疗方案可以提高输卵管再通率及宫内妊娠率。
Objective To evaluate the clinical value of tubal hysterosalpingography in the treatment of tubal obstruction by fluoroscopy combined with Yuxu No.1. Methods Follow-up and analysis of the Affiliated Hospital of Hebei University diagnosed as tubal obstructive infertility cases. According to the patient’s treatment, divided into treatment group and control group. The treatment group underwent hysterosalpingography and immediately after the solution in the fluoroscopy through the oral administration of traditional Chinese medicine, the group prescription to promote blood circulation, regulating menstruation kidney, according to syndrome differentiation plus or minus cycle therapy; control group only conventional fluid treatment. Statistics and comparative analysis of two groups of tubal recanalization rate and pregnancy rate. Results The study showed that the treatment group, tubal recanalization rate of 98%, intrauterine pregnancy rate as high as 75.6%, while only taking the conventional liquid treatment control group tubal recanalization rate was only 78.4%, pregnancy rate was only 52.9% Tubal recanalization rate and intrauterine pregnancy rate difference was statistically significant; and within six months to 1 year intrauterine pregnancy rate difference was statistically significant. The treatment group was significantly better than the control group. Conclusion Tubal obstruction in infertility patients by hysterosalpingography and fluoroscopy through the liquid, combined with traditional Chinese medicine oral administration of traditional Chinese medicine and Western medicine treatment programs can improve the tubal recanalization rate and intrauterine pregnancy rate.